R. Colamarino; J.J. Dubost; B. Sauvezie
This content is PDF only. Please click on the PDF icon to access.
To the Editors: Topical minoxidil has been commercially available since 1987 for the treatment of baldness. Except for contact dermatitis, it is considered free of adverse reactions (1). Reports of hypertrichosis (2) in parts of the body remote from the site of application and rare cases of nerve or cardiovascular toxicity (3-5), however, suggested the possibility of systemic side effects. We observed a previously unreported "polymyalgia" syndrome in four of our patients on topical minoxidil. All were healthy men, aged 48, 40, 40, and 27, respectively. Topical minoxidil was their only medication; they applied it from twice a day to
Colamarino R, Dubost J, Sauvezie B. Polymyalgia and Minoxidil. Ann Intern Med. 1990;113:256–257. doi: 10.7326/0003-4819-113-3-256_2
Download citation file:
Published: Ann Intern Med. 1990;113(3):256-257.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use